We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
-4.21%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
AUM
$121M
AUM Growth
-$12.5M
Cap. Flow
-$6.4M
Cap. Flow %
-5.31%
Top 10 Hldgs %
74.38%
Holding
590
New
27
Increased
162
Reduced
81
Closed
24

Sector Composition

1 Healthcare 7.9%
2 Financials 4.48%
3 Technology 3.39%
4 Consumer Discretionary 2.75%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$891B
$48.9M 40.53%
113,812
-1,424
-1% -$637K
EFV icon
2
iShares MSCI EAFE Value ETF
EFV
$26B
$14.4M 11.91%
293,559
-11,798
-4% -$584K
IJR icon
3
iShares Core S&P Small-Cap ETF
IJR
$111B
$7.75M 6.43%
82,220
+679
+0.8% +$67.8K
IUSV icon
4
iShares Core S&P US Value ETF
IUSV
$27.2B
$6.12M 5.08%
82,081
-1,813
-2% -$142K
WFC icon
5
Wells Fargo
WFC
$267B
$3.06M 2.54%
74,897
+122
+0.2% +$5.27K
IJH icon
6
iShares Core S&P Mid-Cap ETF
IJH
$123B
$2.99M 2.48%
59,890
+175
+0.3% +$9.17K
AMZN icon
7
Amazon
AMZN
$2.69T
$2.23M 1.85%
17,580
-3,043
-15% -$408K
SHY icon
8
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$1.53M 1.27%
18,939
-301
-2% -$24.4K
OFIX icon
9
Orthofix Medical
OFIX
$481M
$1.48M 1.23%
115,060
-645
-0.6% -$11.6K
IVE icon
10
iShares S&P 500 Value ETF
IVE
$49B
$1.29M 1.07%
8,364
-217
-3% -$35.1K
IJJ icon
11
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.88B
$1.2M 1%
11,926
-264
-2% -$28.2K
HALO icon
12
Halozyme
HALO
$9.2B
$1.2M 0.99%
31,290
-10,500
-25% -$430K
IJS icon
13
iShares S&P Small-Cap 600 Value ETF
IJS
$8.22B
$1.14M 0.94%
12,762
-265
-2% -$25.2K
LLY icon
14
Eli Lilly
LLY
$1.04T
$1.08M 0.9%
2,015
-28
-1% -$14.4K
VOO icon
15
Vanguard S&P 500 ETF
VOO
$984B
$1.02M 0.85%
2,605
+10
+0.4% +$4.09K
MSFT icon
16
Microsoft
MSFT
$2.98T
$981K 0.81%
3,108
+89
+3% +$29.4K
MODN
17
DELISTED
MODEL N, INC.
MODN
$882K 0.73%
36,134
AAPL icon
18
Apple
AAPL
$4.89T
$793K 0.66%
4,633
-187
-4% -$34.3K
SPEM icon
19
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.2B
$774K 0.64%
23,065
-10,018
-30% -$346K
MMM icon
20
3M
MMM
$84.4B
$701K 0.58%
8,953
-24
-0.3% -$2.06K
USB icon
21
US Bancorp
USB
$99.7B
$601K 0.5%
18,181
+114
+0.6% +$4.15K
TNDM icon
22
Tandem Diabetes Care
TNDM
$1.12B
$564K 0.47%
27,170
+2,870
+12% +$78.8K
SPY icon
23
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$558K 0.46%
1,306
-27
-2% -$12K
SONX
24
DELISTED
Sonendo, Inc.
SONX
$521K 0.43%
697,992
+200
+0% +$220
PG icon
25
Procter & Gamble
PG
$353B
$507K 0.42%
3,474
+11
+0.3% +$1.68K

Similar funds

HighMark Wealth Management's Q3 2023 Portfolio in Review

As of Q3 2023, HighMark Wealth Management held 590 positions worth $121M, down 9.4% from $133M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

HighMark Wealth Management withdrew a net $6.4M in Q3 2023, closing 24 positions and reducing 81 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

Against the trend, HighMark Wealth Management opened a new position in Insulet worth $19.9K.

  • HighMark Wealth Management's largest Q3 2023 buy was Insulet: 125 shares worth $19.9K.
  • HighMark Wealth Management added most to Protolabs in Q3 2023, an estimated $145K increase.
  • HighMark Wealth Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $637K.
  • HighMark Wealth Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.16M.
  • HighMark Wealth Management's ten largest holdings make up 74% of its $121M portfolio in Q3 2023.
  • HighMark Wealth Management opened 27 new positions and closed 24 in Q3 2023.
  • HighMark Wealth Management's portfolio value fell 9.4% quarter-over-quarter to $121M.

Based on HighMark Wealth Management's 13F filing for Q3 2023, filed 18 Oct 2023.